Clinical Observation of Edaravone Combination of Butylphthalide in Treatment of Advancing Stroke

Objective: To evaluate the effect of combination of butylphthalide in the treatment of the acute advancing stroke.Method: The incidence of advancing stroke in 72h patients with 120 patients,randomly divided into 60 patients with treatment group and control group with 60 patients.The control group with conventional therapy,namely in the given improve microcirculation,and intracranial pressure regulating blood pressure and blood glucose and other symptomatic treatment given based on SBR peptide 0.2g,daily 3,course of treatment is 14 days;the treatment group on the basis of routine treatment of edaravone 30mg joined 100mL saline infusion,2 times daily,with 14 days,Butylphthalide 0.2g for 3 times a day,14 days in a course.Two cases of the United States of America NIH Stroke Scale(NIHSS) score and ability of daily living(BI) score.Result:Treatment group and control group in the NIHSS score and BI score in the 14 days after treatment,1 month are statistical differences(P 0.05).Conclusion:The application effect of edaravone combined butylphthalide is better than that of butylphthalide treating progressing stroke.